Medicare Enrolled
Dr. Muhammed Zahra, MD
Cardiovascular Disease · Cleveland, OH
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zahra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zahra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zahra
Dr. Muhammed Zahra is a cardiovascular disease specialist in Cleveland, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zahra performed 2,862 Medicare services across 1,926 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zahra received a total of $6,393 from 29 pharmaceutical and/or device companies across 345 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zahra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in OH
$6,393 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,862
Medicare services
Top 16% in OH for cardiovascular disease
1,926
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~143 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
508 | $10 | $90 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $85 | $190 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
352 | $43 | $75 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
265 | $123 | $325 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
192 | $32 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
161 | $59 | $135 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
126 | $303 | $675 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
96 | $46 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
89 | $132 | $295 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
84 | $61 | $110 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
72 | $121 | $266 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
55 | $8 | $9 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
47 | $92 | $160 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
41 | $8 | $16 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $118 | $250 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
35 | $20 | $50 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
31 | $100 | $200 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
30 | $19 | $115 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
26 | $7 | $13 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
22 | $598 | $1,227 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
19 | $22 | $59 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
19 | $6 | $30 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
18 | $4 | $8 |
| New patient office visit, complex (60-74 min) | 18 | $146 | $330 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
17 | $6 | $11 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
15 | $16 | $40 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
15 | $11 | $35 |
| Cardiac catheterization | 13 | $212 | $545 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
11 | $12 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.7% high complexity
29.0% medium
61.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,393
Total received (2018-2024)
Avg $913/year across 7 years
Top 27% in OH for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
345
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,082 (95.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$311 (4.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$998
2023
$865
2022
$1,001
2021
$1,614
2020
$474
2019
$793
2018
$649
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$166
SCPHARMACEUTICALS INC.
$150
Azurity Pharmaceuticals, Inc.
$139
Novartis Pharmaceuticals Corporation
$99
Actelion Pharmaceuticals US, Inc.
$89
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Novo Nordisk Inc
$68
Amgen Inc.
$43
PFIZER INC.
$41
Lexicon Pharmaceuticals, Inc.
$31
Esperion Therapeutics, Inc.
$24
United Therapeutics Corporation
$24
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$23
AstraZeneca Pharmaceuticals LP
$23
Top 3 companies account for 45.7% of 2024 payments
All-time payments by company (2018-2024) ›
United Therapeutics Corporation
$845
Janssen Pharmaceuticals, Inc
$728
Actelion Pharmaceuticals US, Inc.
$586
Novartis Pharmaceuticals Corporation
$568
E.R. Squibb & Sons, L.L.C.
$449
AstraZeneca Pharmaceuticals LP
$394
Boehringer Ingelheim Pharmaceuticals, Inc.
$297
Bayer HealthCare Pharmaceuticals Inc.
$266
Novo Nordisk Inc
$239
Kowa Pharmaceuticals America, Inc.
$225
PFIZER INC.
$201
Azurity Pharmaceuticals, Inc.
$200
Astellas Pharma US Inc
$198
Amgen Inc.
$176
SCPHARMACEUTICALS INC.
$150
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$148
Amarin Pharma Inc.
$139
SANOFI-AVENTIS U.S. LLC
$127
Esperion Therapeutics, Inc.
$102
ARBOR PHARMACEUTICALS, INC.
$100
Gilead Sciences, Inc.
$55
Regeneron Healthcare Solutions, Inc.
$41
Arbor Pharmaceuticals, Inc.
$38
Lexicon Pharmaceuticals, Inc.
$31
Bayer Healthcare Pharmaceuticals Inc.
$24
Abbott Laboratories
$21
GENZYME CORPORATION
$20
Braemar Manufacturing, LLC
$13
Allergan Inc.
$12
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
Adempas · BRILINTA · BYSTOLIC · CAMZYOS · Cardiac Monitoring Suite · CardioMEMS HF System · Corlanor · EDARBYCLOR · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · FABRAZYME · FARXIGA · FUROSCIX · HORIZANT · JARDIANCE · Kerendia · LEQVIO · LifeVest · Livalo · MULTAQ · NEXLETOL · NONE · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RYBELSUS · Repatha · Rybelsus · TYVASO · UPTRAVI · VYNDAQEL · Vascepa · Verquvo · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
148
Per 100K population
11.8
County median income
$62,823
Nearest hospital
LUTHERAN HOSPITAL
1.5 mi
1.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zahra is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 16% in OH), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zahra experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Zahra performed 508 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zahra receive payments from pharmaceutical companies?
Yes. Dr. Zahra received a total of $6,393 from 29 companies across 345 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zahra's costs compare to other cardiologists in Cleveland?
Dr. Zahra's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zahra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Cleveland
Browse cardiologists in Cleveland ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in OH
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in OH
Which OH cardiologists receive the most from drug and device companies.
By company
United Therapeutics Corporation Payments to Doctors
See all physicians who received payments from United Therapeutics Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology